Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Equity Ratio: 2021

Historic Equity Ratio for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to 0.87.

  • Cardiol Therapeutics' Equity Ratio fell 24.08% to 2.15 in Q3 2022 from the same period last year, while for Sep 2022 it was 2.15, marking a year-over-year decrease of 24.08%. This contributed to the annual value of 0.87 for FY2021, which is N/A change from last year.
  • Cardiol Therapeutics' Equity Ratio amounted to 0.87 in FY2021.
  • In the past 5 years, Cardiol Therapeutics' Equity Ratio ranged from a high of 0.87 in FY2021 and a low of 0.87 during FY2021.
  • Over the past 1 years, Cardiol Therapeutics' median Equity Ratio value was 0.87 (recorded in 2021), while the average stood at 0.87.